cardiovascular

The financing comes on top of the company's $900 million annual research and development investment in the U.S.

The funding comes more than a year after the company closed an oversubscribed $31.4 million Series B round.

Ambre Health CTO and co-founder Brek Wilkins One of the biggest complaints about healthcare, one of the biggest pain points that digital technology promises to solve, is that data sits in silos, so that even if a piece of data could help a patient, it might not be in the hands of the doctor who needs to see it.